Agilent Technologies acquires Molecular Imaging and its atomic force microscopy technology
Acquisition strengthens Agilent's nanomeasurements portfolio
Agilent Technologies Inc. announced that it has acquired privately held molecular imaging Corp., a developer and manufacturer of nanotechnology measurement tools. Financial details were not disclosed.
Based in Tempe, Ariz., Molecular Imaging is known for its atomic force microscopes (AFMs), the principal imaging and measurement instruments used by researchers working in nanotechnology. Called the "eyes of nanotechnology," AFMs are used to measure the shape and properties of materials at the nanometer scale.
Agilent already has a solid position in the laser interferometer market to precisely measure distances at the nanometer scale. The acquisition of Molecular Imaging marks the next step in strengthening Agilent's market position in nanomeasurement by extending the company's portfolio into imaging at the nanometer scale through AFMs.
Other news from the department business & finance

Get the chemical industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.
Most read news
More news from our other portals
Last viewed contents
Eagle_Diamond
Debashis_Mukherjee
Gemcitabine
Rockwell Automation Reports First Quarter 2012 Results and Reaffirms Guidance
Bioadhesives Poised to Replace Synthetic Solutions - The sector has vast technological capabilities with scope in wider applications

LabVantage Solutions Names Digital Transformation Veteran Mikael Hagstroem as Chief Executive Officer
Stanozolol
